GPOH: Who We Are
“The purpose of GPOH is to research the origin, diagnosis and therapy of paediatric tumour and blood diseases as well as to improve the structural preconditions required to do so.”
The Society for Paediatric Oncology and Haematology is an interdisciplinary, international German language scientific organisation. Physicians, researchers, nurses and psychologists are members of the society. They are committed to comprehensive research, diagnosis, treatment and follow-up care of children and adolescents suffering from malignant diseases and blood diseases.
- The society fosters scientific exchange and research co-operation.
- For the last 25 years, the largest field of activity has been the therapy optimising trials. These therapy optimising trials carried out in cooperation with multiple centres have been performed for almost all malignant diseases occurring in childhood and adolescence, are further enhanced and applied throughout all German speaking countries. Evidence proves that they ensure that children and young adults receive the best possible overall treatment concept.
The Society for Paediatric Oncology and Haematology absorbed the associations "German Study Group for Leukaemia Research" (DAL, founded in 1965) and the "Society for Paediatric Oncology (GPO, founded in 1974). In turn with this merger taking place in November 1991, the society's aims were extended to include the field of non-oncological haematology and thus the society's new name reflects this change.
The Society for Paediatric Oncology and Haematology is a non-profit organisation with their registered seat in Frankfurt/Main. The society's mission is researching the origin, diagnostics and therapy of malignant diseases and blood diseases in children and adolescents and improvement of the structural preconditions required to meet these aims. The society consists of various elements (members' general meeting, executive board and advisory council), whose tasks are stipulated in the society's articles. It represents a number of study groups, central services and research institutions.
Executive, extended executive and advisory committee
Following the Society's by-law, e new executive committee was elected after two terms of office at the members' meeting, September 14, 2012 in Hamburg, Germany
Members of the Society for Paediatric Oncology and Haematology